Updated information and services can be found at: Nitric oxide (NO) exerts microbicidal effects on a broad spectrum of pathogens, including viruses, but its antiretrovirus properties have not yet been described. The purpose of this study was to determine whether NO inhibits murine Friend leukemia virus (FV) replication in vitro and to what extent NO may play a role in defenses against FV infection in mice. Three NO-generating compounds were studied: 3-morpholino-sydononimine (SIN-1), sodium nitroprusside (SNP), and S-nitroso-N-acetylpenicillamine (SNAP). The effects of these three compounds were compared with those of their controls (SIN-1C, potassium ferricyanide, and N-acetylpenicillamine, respectively), which do not generate NO and with that of sodium nitrite (NaNO 2 ). SIN-1, SNP, and SNAP inhibited FV replication in dunni cells in a concentration-dependent manner. In contrast, no significant inhibitory effect was observed with the three controls or NaNO 2 . Furthermore, the addition of superoxide dismutase did not alter the inhibitory effect of SIN-1, which is also known to generate superoxide anions. No dunni cell toxicity was observed in the range of concentrations tested. We also assessed the effect of NO produced by activated macrophages on FV replication. Macrophages activated by gamma interferon and lipopolysaccharide inhibited FV replication in a concentration-dependent manner. This inhibition was due in part to NO production, since it was reversed by N 
Friend leukemia virus (FV) is a retrovirus complex composed of a replication-competent helper virus (Friend murine leukemia virus [F-MuLV] ) and a replication-defective virus (spleen focus-forming virus) (20, 37) . Mice infected with FV develop acute erythroleukemia and succumb within 3 to 6 weeks (32) . In addition, infection with FV leads to the dysfunction of a wide range of immunocompetent cells, including T cells, B cells, and macrophages (37) . FV infection diminishes the ability of B cells to mount antibody responses against various neoantigens (8) and leads to polyclonal B-cell activation (1), suppressed T-cell cytotoxicity (12) , and depressed antigen presentation by macrophages (19) .
Nitric oxide is a free radical generated by nitric oxide synthase from L-arginine, which is converted into citrulline plus nitric oxide (NO) (16, 23, 38, 41) . NO mediates numerous physiological functions, including host defenses (30) . NO and related reactive nitrogen intermediates exert microbiostatic and microbicidal activity against a broad spectrum of bacteria (2, 9, 11, 40) and parasites (5, 15, 18, 22, 25, 26, 34) . Furthermore, NO has recently been shown to have activity against herpes simplex virus type 1 and ectromelia and vaccinia viruses (4, 21) . However, the antiretrovirus properties of NO have not so far been described. The purpose of this study was to determine whether NO inhibits FV replication in vitro and in vivo.
MATERIALS AND METHODS
Nitric oxide-generating compounds and reagents. Several NO donors and their chemical controls which do not release NO, respectively, were used in this study: 3-morpholino-sydononimine (SIN-1) and cyanomethylenamino-morpholine (SIN-1C) (both from Hoechst, Paris, France), S-nitroso-N-acetylpenicillamine (SNAP) (Biomol Research Laboratories, Tebu, France) and N-acetylpenicillamine (NAP) (Sigma Chemical Co. St. Louis, Mo.), and sodium nitroprusside (SNP) and potassium ferricyanide (KFC) (Sigma Chemical Co.). The other reagents, namely, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), superoxide dismutase (SOD), sodium nitrite (NaNO 2 ), lipopolysaccharide (LPS) (Escherichia coli serotype O55:B5), 3-amino-9-ethylcarbazole 
, and L-and D-arginine were from Sigma Chemical Co. Recombinant murine interferon gamma (IFN-␥) was from Genzyme (Cambridge, Mass.).
Mice. Male DBA/2 mice aged 6 weeks were purchased from IFFA Credo Laboratories, Grenoble, France. Animals were acclimatized for 1 week prior to use. They were housed in an air-conditioned room in accordance with guidelines for care and use of laboratory animals.
Dunni fibroblast cell line and Friend virus. Dunni cells, a fibroblast cell line (generous gift from M. Sitbon, Paris, France), were cultured in culture medium (RPMI 1640 medium [GIBCO, Grand Island, N.Y.] supplemented with 10% fetal calf serum, 1% glutamine, 100 U of penicillin per ml, and 100 g of streptomycin per ml) at 10 6 /ml. A total of 5 ϫ 10 4 dunni cells per well were plated in 2 ml of culture medium per well in 12-well tissue culture plates (Costar) and maintained for 24 h before viral inoculation at 37ЊC with 5% CO 2 . Cell-free viral stocks of Friend virus complex (FV) used for in vitro studies were prepared from chronically infected dunni cells. Titration was performed by measuring FV replication in dunni cells by the immunoperoxidase technique previously described by Sitbon et al. (36) : after incubation with virus suspension for 24 h, confluent monolayers were washed, incubated 48 h later with 0.5 ml of undiluted supernatant from cultures of a specific antiviral monoclonal antibody-producing hybridoma (monoclonal antibody 48) for 30 min at room temperature, and rinsed with phosphate-buffered saline (PBS). The wells were then incubated for 30 min at room temperature with peroxidase-conjugated goat anti-mouse immunoglobulins (Cappel). The substrate, 3-amino-9-ethylcarbazole in dimethylformamide, was added after the plates were rinsed with TNE (0.01 M Tris HCl [pH 7.8], 0.15 M NaCl, 2 mM EDTA) and incubated in the dark for 20 min at room temperature. Plates were rinsed with distilled water, and foci were counted. The virus titer was expressed in focus-forming units (FFU) per milliliter. For in vivo studies, stocks of Friend virus complex (gift from P. Tambourin, Paris, France) were prepared as spleen homogenates from infected DBA/2 mice as previously described (35) . Aliquots were stored at Ϫ80ЊC and titrated for infectivity in vivo by the spleen focus assay (35) . Mice were inoculated intravenously with 0.2 ml of low-titer virus suspension (5 FFU) in order to obtain countable foci at the spleen surface.
Peritoneal macrophages. Peritoneal macrophages were obtained 3 days after injecting mice (intraperitoneally) with 2 ml of 3% thioglycolate medium (Difco Laboratories, Detroit, Mich.). Peritoneal cells were harvested by injecting 4 ml of cold PBS supplemented with sodium heparinate (10 U/ml of PBS) into the peritoneal cavity. Cells were washed twice with cold PBS, and then macrophages were counted by using nonspecific esterase staining (42) and suspended in culture medium at 10 6 macrophages per ml. Antiviral activity of NO-generating compounds and macrophages. FV (50 FFU) suspended in 0.5 ml of culture medium was added to 5 ϫ 10 4 cultured dunni cells. Twenty-four hours later, the dunni cells were washed and NOgenerating compounds or macrophages were added to the cultures.
The NO-generating compounds (SIN-1, SNP, and SNAP), diluted in culture medium, were added at various concentrations (0.2, 1, 5, 20, and 100 M) to FV-infected dunni fibroblasts. The controls (SIN-1C, KFC, and NAP, respectively) were tested at the same concentrations. NaNO 2 (100 M) was also tested to assess the specific activity of NO. Since SIN-1 also releases superoxide anions (10), in some experiments SOD was added concomitantly with SIN-1 (1 U/1 M SIN-1).
Macrophages were added to FV-infected dunni cells at ratios of 2:1, 1:1, 1:5, and 1:10 (determined taking into account the initial number of fibroblasts plated). The 2:1 ratio was the maximum value not eliciting macrophage cytotoxicity against dunni cells. Culture medium containing LPS (50 ng/ml) plus IFN-␥ (25 U/ml) or culture medium alone was added to the cultures in the presence or absence of a competitive inhibitor of L-arginine, L-NMMA (10 Ϫ3 M). To further authenticate the specificity of L-NMMA, L-or D-arginine (5 mM) were also added to the cultures in some experiments.
After 2 additional days of culture after adding NO-generating compounds or macrophages, supernatants were harvested and stored at Ϫ20ЊC until assay for nitrite production; FV replication in dunni cells was evaluated by means of immunoperoxidase staining as described above. Results (FFU per well) are the mean of duplicate counts. Fifty-percent inhibitory concentrations were calculated from the regression line of focus inhibition versus log drug concentration.
Nitrite determination. Nitrite (NO 2
Ϫ
) is a stable compound produced by the reaction of NO with water and oxygen, and its accumulation in culture medium reflects the amount of NO produced. The concentration of NO 2 Ϫ was determined by mixing equal volumes (100 l) of the sample with Griess reagent (1% sulfanilamide, 2.5% phosphoric acid, 0.1% naphtylethylene diamine) in 96-well microtiter plates (14) , and then the A 550 was measured. The concentration of NO 2 Ϫ in the supernatant was calculated from a standard curve which was linear between 0 and 200 M sodium nitrite. Assays were done in duplicate.
Cell viability. Cell viability was determined by the standard MTT assay (6), notably with appropriate concentrations of NO donors and their controls.
Effect of L-NAME supply to FV-infected mice. To evaluate the effect of NO production on FV replication in vivo, mice were treated with a competitive inhibitor of L-arginine, L-NAME (31) , given in drinking water (500 mg/liter). Treatment was begun 5 days before infection and continued throughout the course of the infection. Control mice were given sterile distilled water. The water and L-NAME receptacles were weighed and changed twice a week. Mice infected on day 0 were killed 1, 2, and 3 weeks postinoculation; the spleens were weighed and fixed in Bouin's fixative. Yellow focal lesions on the planar surface of the spleen were counted macroscopically. Other mice were killed at the same times, and spleen cell suspensions were prepared from control and L-NAME-treated FV-infected mice. After the cells were washed twice with culture medium, they were counted and adjusted to densities of 10 6 , 2 ϫ 10 5 , 4 ϫ 10 4 , and 8 ϫ 10 3 /ml. Spleen cell suspension (0.5 ml) was added to plated dunni cells (5 ϫ 10 4 per well) and titrated by immunoperoxidase staining as described above. The hematocrit was measured by centrifuging blood samples taken from the retro-orbital sinus in microcapillary tubes.
Statistical analysis. Results are presented as means Ϯ standard errors of the means (SEMs). Statistical significance (P Ͻ 0.05) was determined by Student's t test.
RESULTS
Effects of nitric oxide-generating compounds on FV replication. As shown in Fig. 1A and 2 , the NO donor SIN-1 and SNP inhibited FV replication in dunni cells in a concentrationdependent manner, whereas their controls, SIN-1C and KFC, respectively, had no significant effect. The 50% inhibitory concentrations of SIN-1 and SNP were 0.8 and 0.9 M, respectively. The concomitant addition of SOD, an O 2 ⅐ Ϫ scavenger, did not alter the inhibitory effect of SIN-1 (Fig. 1B) . As shown in Fig. 3 , SNAP also significantly inhibited FV replication in a concentration-dependent manner (50% inhibitory concentration of 3 M); although its control, NAP, was also inhibitory, the difference between SNAP and NAP was significant at 100 M. Moreover, we checked the efficiencies of NO donors by measuring nitrites in the culture medium after adding the different drugs: while we detected significant amounts of nitrite related to the concentrations of SIN-1, SNP, and SNAP added, no nitrite was detectable in the presence of their respective controls (data not shown). In addition, to assess specific NO activity, the effects of SIN-1, SNP, and SNAP were compared with that of NaNO 2 : in contrast to the NO donors, NaNO 2 (100 M) did not affect FV replication (data not shown).
The NO-induced decrease in FV replication was not due to cellular toxicity: SIN-1, SNP, and SNAP failed to modify, at any of the concentrations tested, the viability of noninfected or FV-infected dunni cells, which was always more than 90% after 48 h of incubation (data not shown). However, NAP killed about 25% of cells, which could explain its nonspecific inhibitory effect.
Effects of NO produced by activated macrophages on FV replication. As shown in Table 1 , in the presence of LPS (50 ng/ml) and IFN-␥ (25 U/ml), macrophages inhibited FV replication in a concentration-dependent manner. The largest decrease in FV foci counts was observed with a macrophage/ fibroblast ratio of 2:1 (84% inhibition compared with the value for macrophages in the absence of LPS and IFN-␥). The in- hibitory effect can be attributed to activated macrophages, since LPS and IFN-␥ did not inhibit FV replication in the absence of macrophages. The ability of IFN-␥-and-LPS-activated macrophages to inhibit FV replication coincided with the production of significant amounts of NO 2 Ϫ in the culture supernatant ( Table 2 ). The NO 2 Ϫ level decreased gradually in the culture supernatant, in parallel with the decrease in macrophage numbers. In contrast, we detected no NO 2 Ϫ in the culture supernatant of unstimulated macrophages. The antiviral effect could be attributed to NO production by stimulated macrophages, because the addition of L-NMMA, a competitive inhibitor of NO synthase, substantially reduced the ability of activated macrophages to inhibit FV replication (Table 1 ). In addition, treatment with L-NMMA coincided with a major decrease in nitrite production by activated macrophages (Table 2). Finally, as shown in Tables 1 and 2 
Effects of L-NAME on FV replication in vivo.
To investigate the physiological relevance of these in vitro findings, we treated mice with L-NAME, an inhibitor of NO formation from L-arginine (31) , and tested its effect on the FV concentration in the spleens of infected mice. As shown in Fig. 4A , the macroscopic spleen focus-forming virus foci count in the spleens of L-NAME-treated mice was significantly higher than in control infected mice 1, 2, and 3 weeks postinfection. These results were confirmed by counting F-MuLV foci by the immunoperoxidase technique in dunni cells after incubation with spleen cell suspension (10 6 cells per ml) (Fig. 4B) . Similar results were obtained with lower dilutions of spleen cells (2 ϫ 10 5 , 4 ϫ 10 4 , and 8 ϫ 10 3 /ml). L-NAME-treated mice did not lose weight relative to untreated mice, and their fluid intake was normal. Since FV replicates in erythroid target cells, we checked that L-NAME treatment did not modify erythropoiesis: hematocrit values 1, 2, and 3 weeks postinfection were not altered by L-NAME treatment (Table 3) . Hematocrit and spleen weight in FV-infected mice were not higher than in noninfected mice in these experiments, because a small inoculum of FV (5 FFU per mouse) was used to obtain countable foci at the spleen surface. a Nitrite was measured as described in Materials and Methods in culture supernatant of 5 ϫ 10 4 FV-infected fibroblasts after the addition of various numbers of macrophages. Culture medium alone or supplemented with LPS (50 ng/ml), IFN-␥ (25 U/ml), L-NMMA (10 Ϫ3 M), and L-arginine (5 mM) was used. Each value is the mean of two duplicates in this experiment, which is representative of three experiments. ND, not done.
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DISCUSSION
These results show that NO produced by NO-generating compounds or activated macrophages inhibits FV replication in fibroblast cultures and is involved in defenses against FV in vivo. To our knowledge, this is the first evidence of a role of NO in host defenses against a murine retrovirus.
In spite of their biochemical differences, all three NO donors (SIN-1, SNP, and SNAP) inhibited FV replication. In contrast, their respective controls (SIN-1C, KFC, and NAP), which have very similar chemical structures but do not generate NO, did not significantly inhibit the replication of FV. The specific involvement of NO in the inhibitory effect of FV replication is further supported by the fact that SOD, an O 2 ⅐ Ϫ scavenger, did not influence this effect. NaNO 2 was used to determine whether NO metabolites contributed to the inhibitory effect, but focus counts were identical to those of untreated controls. The NO donor-induced reduction in FV focus numbers cannot be attributed to target cell viability, since the latter was not impaired at any of the concentrations or incubation times used.
Macrophages play a major role in host defenses against various pathogens and tumor cells, and NO is essential for these functions (2, 3, 5, 9, 11, 15, 17, 18, 22, 25-27, 29, 34, 40) . Our results showed that the inhibition of FV replication could be attributed to activated macrophages, since LPS plus IFN-␥ did not significantly inhibit FV replication in the absence of macrophages. The inhibitory effect of LPS-and-IFN-␥-activated macrophages can be attributed, at least in part, to NO production: indeed, the inhibitory effect was reduced in the presence of a competitive inhibitor of L-arginine, L-NMMA. The specificity of L-NMMA activity in our experimental model was further shown by the suppression of its inhibitory effect by L-arginine in excess, but not by D-arginine. In addition, inhibition of FV replication by macrophages in the presence of LPS and IFN-␥ coincided with the production of nitrites, which derived from the effector molecule, NO (7, 9) . Taken together, these results suggest that NO produced by LPS-and-IFN-␥-activated macrophages contributes to the inhibition of FV replication in dunni cells.
To evaluate the possible involvement of NO production in defenses against this murine retrovirus, we tested the impact of an NO synthase inhibitor on viral replication in vivo. FVinfected mice treated with L-NAME and killed 1, 2, and 3 weeks postinoculation had higher numbers of spleen focusforming virus-induced foci on the spleen and F-MuLV titers in spleen cells. NO has been described as having antimicrobial effects on a variety of pathogens (2, 5, 11, 15, 18, 22, 25, 26, 34, 40) . Recently (4, 21) , it has been shown that NO also has an antiviral effect, as shown by the correlation between the inhibition of ectromelia, vaccinia, and herpes simplex type 1 virus replication and macrophage NO production and also by the concentration-dependent inhibition of the replication of these viruses by SNAP, an NO donor. Our results are in keeping with these data and suggest that NO production may play a role in defenses against the FV murine retrovirus in vivo, even if this mechanism does not completely inhibit viral replication.
NO typically interacts with iron-containing proteins and interferes with the function of ribonucleotide reductase. Inhibition of several cellular ribonucleotide reductases by NO has been described and may account for some of its cytostatic properties (24) . However, our results showing that NO donors inhibit FV replication in vitro are probably not related to decreased proliferation of target cells, because the number of dunni cells was not modified in these experimental conditions. In FV-infected mice, the L-NAME-induced increase in FV   FIG. 4 . Impact of a NO synthase inhibitor, L-NAME, given in the drinking water (500 mg/liter), on the course of FV infection in mice. (A) The number of spleen focus-forming virus foci in splenocytes was significantly higher in L-NAME-treated mice at weeks 1 (P Յ 0.01), 2 (P Յ 0.001), and 3 (P Յ 0.0001) than in either set of untreated infected mice. (B) Viral titers of F-MuLV in 10 a L-NAME (500 mg/liter) was given to DBA/2 mice as described in Materials and Methods. FV-infected mice received 5 FFU given intravenously as described in Materials and Methods.
replication could be related to NO-induced inhibition of erythroid target cells, as described with other inhibitors of ribonucleotide reductase such as hydroxyurea (33, 39) . However, it has been shown that hydroxyurea also abolishes human immunodeficiency virus type 1 DNA synthesis in peripheral blood mononuclear cells, without clear evidence of toxicity for target cells (28) . Therefore, inhibition of ribonucleotide reductase might contribute to the sensitivity of FV to NO. Other mechanisms could also be involved, such as deamination of viral DNA (43) or reaction of NO with superoxide anions produced by phagocytes to form peroxynitrite anions that decompose into highly destructive hydroxyl radicals (13) . These radicals could participate in host defenses against particular retroviruses. A better understanding of the way in which NO inhibits FV replication may provide useful insights into the pathogenesis of other retrovirus-caused diseases such as AIDS.
